Diabetes Care, Vol 17, Issue 5 372-375, Copyright © 1994 by American Diabetes Association

ARTICLES

Weight loss in severely obese subjects prevents the progression of impaired glucose tolerance to type II diabetes. A longitudinal interventional study

SD Long, K O'Brien, KG MacDonald, N Leggett-Frazier, MS Swanson, WJ Pories and JF Caro
Department of Medicine, East Carolina University, Greenville, North Carolina.

OBJECTIVE--To determine if weight loss may prevent conversion of impaired glucose tolerance (IGT) to diabetes, because weight loss reduces insulin resistance. The prevalence of IGT in the U.S. population is estimated at 11.2%, more than twice that of diabetes. Furthermore, because an oral glucose tolerance test is needed for its detection, most of these patients are undiagnosed. Screening for IGT would be meaningful if progression to diabetes could be delayed or prevented. RESEARCH DESIGN AND METHODS--For an average of 5.8 years (range 2-10 years), 136 individuals with IGT and clinically severe obesity (> 45 kg excess body weight) were followed. The experimental group included 109 patients with IGT who underwent bariatric surgery for weight loss. The control group was made up of 27 subjects with IGT who did not have bariatric surgery. The criteria of the World Health Organization was used to detect IGT and diabetes in this population. The main outcome measure of this nonrandomized control trial is the incidence density, or number of events (development of diabetes) divided by the time of exposure to risk. RESULTS--Of the 27 subjects in the control group, 6 developed diabetes during an average of 4.8 +/- 2.5 years of postdiagnosis follow-up, yielding a rate of conversion to diabetes of 4.72 cases per 100 person-years. The 109 individuals of the experimental group were followed for an average of 6.2 +/- 2.5 years postbariatric surgery. Based on the 95% confidence interval of the comparison group, we would expect to find that between 22 and 36 subjects in the experimental group developed diabetes over the follow-up period. Only 1 of the 109 experimental-group patients developed diabetes, resulting in a conversion rate of the experimental group of only 0.15 cases per 100 person-years, which is significantly lower (P < 0.0001) than the control group. CONCLUSIONS--Weight loss in patients with clinically severe obesity prevents the progression of IGT to diabetes by > 30-fold.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. J. Franz The Evidence Is In: Lifestyle Interventions Can Prevent Diabetes American Journal of Lifestyle Medicine, March 1, 2007; 1(2): 113 - 121. [Abstract] [PDF]

				E. Naslund and J. G. Kral Impact of Gastric Bypass Surgery on Gut Hormones and Glucose Homeostasis in Type 2 Diabetes Diabetes, December 1, 2006; 55(Supplement_2): S92 - S97. [Abstract] [Full Text] [PDF]

				K. M. Utzschneider and D. L. Trence Effectiveness of Gastric Bypass Surgery in a Patient With Familial Partial Lipodystrophy. Diabetes Care, June 1, 2006; 29(6): 1380 - 1382. [Full Text] [PDF]

				A. E. Pontiroli, F. Folli, M. Paganelli, G. Micheletto, P. Pizzocri, P. Vedani, F. Luisi, L. Perego, A. Morabito, and S. Bressani Doldi Laparoscopic Gastric Banding Prevents Type 2 Diabetes and Arterial Hypertension and Induces Their Remission in Morbid Obesity: A 4-year case-controlled study Diabetes Care, November 1, 2005; 28(11): 2703 - 2709. [Abstract] [Full Text] [PDF]

				K. P. Truesdale, J. Stevens, and J. Cai The Effect of Weight History on Glucose and Lipids: The Atherosclerosis Risk in Communities Study Am. J. Epidemiol., June 15, 2005; 161(12): 1133 - 1143. [Abstract] [Full Text] [PDF]

				V. F. Garcia Adolescent Bariatric Surgery: Treatment Delayed May Be Treatment Denied Pediatrics, March 1, 2005; 115(3): 822 - 823. [Full Text] [PDF]

				R. P. Trevino, A. E. Hernandez, Z. Yin, O. A. Garcia, and I. Hernandez Effect of the Bienestar Health Program on Physical Fitness in Low-Income Mexican American Children Hispanic Journal of Behavioral Sciences, February 1, 2005; 27(1): 120 - 132. [Abstract] [PDF]

				R. P. Trevino, Z. Yin, A. Hernandez, D. E. Hale, O. A. Garcia, and C. Mobley Impact of the Bienestar School-Based Diabetes Mellitus Prevention Program on Fasting Capillary Glucose Levels: A Randomized Controlled Trial Arch Pediatr Adolesc Med, September 1, 2004; 158(9): 911 - 917. [Abstract] [Full Text] [PDF]

				N. Younis, H. Soran, and S. Farook The prevention of type 2 diabetes mellitus: recent advances QJM, July 1, 2004; 97(7): 451 - 455. [Abstract] [Full Text] [PDF]

				S. Ten and N. Maclaren Insulin Resistance Syndrome in Children J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2526 - 2539. [Abstract] [Full Text] [PDF]

				D. E. Cummings, J. Overduin, and K. E. Foster-Schubert Gastric Bypass for Obesity: Mechanisms of Weight Loss and Diabetes Resolution J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2608 - 2615. [Full Text] [PDF]

				J. S Torgerson Review: Preventing diabetes in the obese: the XENDOS study and its context The British Journal of Diabetes & Vascular Disease, January 1, 2004; 4(1): 22 - 27. [Abstract] [PDF]

				D. Eisenberg and R. L. Bell The Impact of Bariatric Surgery on Severely Obese Patients With Diabetes Diabetes Spectr, October 1, 2003; 16(4): 240 - 245. [Abstract] [Full Text] [PDF]

				E. V. Polyzogopoulou, F. Kalfarentzos, A. G. Vagenakis, and T. K. Alexandrides Restoration of Euglycemia and Normal Acute Insulin Response to Glucose in Obese Subjects With Type 2 Diabetes Following Bariatric Surgery Diabetes, May 1, 2003; 52(5): 1098 - 1103. [Abstract] [Full Text] [PDF]

				K. G. MacDonald Jr Overview of the Epidemiology of Obesity and the Early History of Procedures to Remedy Morbid Obesity Arch Surg, April 1, 2003; 138(4): 357 - 360. [Full Text] [PDF]

				G. M. Reaven Importance of Identifying the Overweight Patient Who Will Benefit the Most by Losing Weight Ann Intern Med, March 4, 2003; 138(5): 420 - 423. [Abstract] [Full Text] [PDF]

				B. O. Ogunnaike, S. B. Jones, D. B. Jones, D. Provost, and C. W. Whitten Anesthetic Considerations for Bariatric Surgery Anesth. Analg., December 1, 2002; 95(6): 1793 - 1805. [Full Text] [PDF]

				S. E. Greenway, F. L. Greenway III, and S. Klein Effects of Obesity Surgery on Non-Insulin-Dependent Diabetes Mellitus Arch Surg, October 1, 2002; 137(10): 1109 - 1117. [Abstract] [Full Text] [PDF]

				A. E. Pontiroli, P. Pizzocri, M. C. Librenti, P. Vedani, M. Marchi, E. Cucchi, C. Orena, M. Paganelli, M. Giacomelli, G. Ferla, et al. Laparoscopic Adjustable Gastric Banding for the Treatment of Morbid (Grade 3) Obesity and its Metabolic Complications: A Three-Year Study J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3555 - 3561. [Abstract] [Full Text] [PDF]

				J. B. Dixon and P. E. O'Brien Health Outcomes of Severely Obese Type 2 Diabetic Subjects 1 Year After Laparoscopic Adjustable Gastric Banding Diabetes Care, February 1, 2002; 25(2): 358 - 363. [Abstract] [Full Text] [PDF]

				D. E. Kelley and B. H. Goodpaster Skeletal Muscle Triglyceride: An aspect of regional adiposity and insulin resistance Diabetes Care, May 1, 2001; 24(5): 933 - 941. [Abstract] [Full Text]

				S. B. Heymsfield, K. R. Segal, J. Hauptman, C. P. Lucas, M. N. Boldrin, A. Rissanen, J. P. H. Wilding, and L. Sjostrom Effects of Weight Loss With Orlistat on Glucose Tolerance and Progression to Type 2 Diabetes in Obese Adults Arch Intern Med, May 8, 2000; 160(9): 1321 - 1326. [Abstract] [Full Text] [PDF]